SCM
ABBV icon

Stonehearth Capital Management’s AbbVie ABBV Stock Holding History

Stonehearth Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-920
Closed -$200K – 95
2026
Q1 		$200K Hold
920
– – 0.08% 96
2025
Q4 		$210K Hold
920
– – 0.08% 95
2025
Q3 		$213K Buy
+920
New +$187K 0.08% 91

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Stonehearth Capital Management's ABBV Position: Q2 2026 in Review

Stonehearth Capital Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 920 shares — an estimated $200K sold.

Stonehearth Capital Management first reported a position in ABBV in Q3 2025 and held it in 3 quarters. The position peaked at $213K in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Stonehearth Capital Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Stonehearth Capital Management sold 920 AbbVie shares in Q2 2026, an estimated $200K.
  • Stonehearth Capital Management first reported a position in AbbVie in Q3 2025 and held it in 3 quarters.
  • Stonehearth Capital Management's AbbVie position peaked at $213K in Q3 2025.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stonehearth Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.